Roy H. Decker, MD/PhD

Associate Professor of Therapeutic Radiology; Disease Aligned Research Team Leader, Therapeutic Radiology, Yale Cancer Center; Director, Residency Training Program; Director, Thoracic/Stereotactic Body Radiotherapy Program; Vice Chair for Clinical Research

Clinical Interests

  • Radiation Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Child
Referrals: From patients or physicians

Patient Care Organizations

Radiation Oncology

Therapeutic Radiology: Head & Neck Radiotherapy | Spine Radiosurgery | Thoracic Radiotherapy

Thoracic Oncology Program

Yale Cancer Center: Head & Neck Cancers Program | Thoracic Oncology Program

Yale Medicine

Office of Cooperative Research

Clinical Trials

Conditions Study Title
Esophagus, Larynx, Lip, Oral Cavity and Pharynx A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
Soft Tissue Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Larynx, Lip, Oral Cavity and Pharynx Single-Arm Phase II Trial of Dual Inhibition of EGFR With Afatinib and Cetuximab With Correlative Studies in the Second-Line Treatment of Recurrent or Metastatic Squamous Cell Cancers of the Head and Neck
Larynx, Lip, Oral Cavity and Pharynx, Ill-Defined Sites A Phase II Study of Pembrolizumab for Patients With Head and Neck Squamous Cell Carcinoma With Residual Disease Following Definitive Chemoradiation
Larynx, Lip, Oral Cavity and Pharynx Phase II Randomized Trial of Adjuvant Radiotherapy With or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Brain and Nervous System A Randomized, Placebo Controlled Phase 2b/3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance 1)
Rectum Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer
Lung, Melanoma, skin Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC
Larynx, Lip, Oral Cavity and Pharynx Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Edit this profile

Contact Info

Roy H. Decker, MD/PhD
Patient Care Location
Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven
35 Park Street, Ste Lower Level

New Haven, CT 06511
View on map...
Office Location
Yale Therapeutic RadiologyHunter Building
15 York Street, Ste HRT 134

New Haven, CT 06510
View on map...
Mailing Address
PO Box 208040
New Haven, CT 06520-8040